Florent Malard, MD, PhD, earned his medical degree from the University of Nantes, Nantes, France, followed by his PhD from the University Pierre et Marie Curie, Paris, France, in 2014.
Dr Malard is currently a Hematologist practicing in Saint Antoine Hospital, Paris, France. He is also an Associate Professor at the Sorbonne University, Paris, France.
Dr Malard is the recipient of various awards such as the ASH Abstract Achievement Award (2015), the French Society of Hematology and Laurette Fugain research award (2014). He also leads the European Society for Blood and Marrow Transplantation (EBMT) Cellular Therapy & Immunobiology Working Party (CTIWP)’s Initiative on Microbiota.
Speaking on gut microbiota diversity, transplantation, and immunotherapy
Dr Malard’s research work largely involves the management of post-allogeneic hematopoietic stem cell transplantation (HSCT) complications such as graft versus host disease (GvHD). He is also the Principal Investigator for a Phase III ARES trial (NCT04769895) exploring the next-generation fecal microbiota transfer product MaaT013 in ruxolitinib-resistant acute GvHD.